Showing 1 - 1 results of 1 for search 'Wanglong Hong', query time: 0.02s Refine Results
  1. 1
    Cost-effectiveness of palbociclib plus fulvestrant as second-line therapy of women with HR+/HER2- advanced breast cancer - A Chinese healthcare system perspective

    Cost-effectiveness of palbociclib plus fulvestrant as second-line therapy of women with HR+/HER2- advanced breast cancer - A Chinese healthcare system perspective by Wentao Zhu, Miaomiao Zheng, Panpan Xia, Wanglong Hong, Guoqiang Ma, Aizong Shen, Aizong Shen

    Published 2023-03-01
    Get full text
    Article

Search Tools: